# Cannabinoid Therapeutics vs. Recreational Use: A Clinical Conundrum

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabinoid-therapeutics-vs-recreational-use/
> **Published:** 2026-10-29T01:12:00-04:00 | **Last Modified / Clinically Audited:** 2026-10-29T01:12:00-04:00
> **Clinical Summary:** When patients transition from recreational cannabis to tailored cannabinoid therapeutics, anxiety drops and sleep improves. Explore the clinical differences.

---

Dr. Caplan’s Clinical Pearl
 

When patients switch from recreational cannabis to individualized cannabinoid therapeutics, they often report a significant reduction in anxiety and improved sleep quality. This is likely due to the tailored dosing and strain selection that addresses their specific endocannabinoid system deficiencies. By optimizing cannabinoid profiles, we can harness the therapeutic potential of cannabis while minimizing its psychoactive effects.

 
 **Clinical Evidence Reference:** [Distinguishing Clinical Cannabinoid Therapeutics from Non-Medical Use (PMID: 42889659)](https://pubmed.ncbi.nlm.nih.gov/42889659/) | [DOI: 10.1016/j.hpopen.2026.100185](https://doi.org/10.1016/j.hpopen.2026.100185)
 
 

 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.
 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Cannabis Consultation](https://cedclinic.com/book/)
 
 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).